NIPT in Finland
Private Clinics
Helsinki University
Hospital
(preparations for
implementation)
Implementation and
immediate evaluation
Other University
Hospitals ?
2013 10/2014 – 12/2014 1.1.2015 autumn 2015
Vedran Stefanovic
Fetomaternal Medical Center
Helsinki University Hospital
Finland
Vedran.stefanovic@hus.fi
1.1.2015 
1.FTS risk ≥ 1:250
2.Nuchal translucency 3-3.9 mm
3.Mid-trimester screen positive
4. > 40 yrs + FTS unattended
5. Previous child/fetus with aneuploidy (21.13 and 18 trisomy, sex-chromosomes aneuploidy)
CVS (ad H14+6) OR
Amnio (H15+0 )
21,18 ja 13-trisomy and sex-chromosomes PCR
Abnormal result
Counselling
1.Nuchal translucency ≥ 4 mm
2.Structural anomaly
CVS (ad H14+6)
OR AMNIO(H15+0)-
Karyotype ( + microarray)
Counselling:
(patients´s choice: invasive
or NIPT)
Counselling
NIPT
Normal result Abnormal result or
inconclusive
No follow-up
Counselling
Amnio
21,18 ja 13-trisomy and sex-
chromosomes PCR
Counselling
*
* NIPT= Non-Invasive Prenatal Testing Vedran Stefanovic® 12/2014
57 56
168
94
51
23
163
127
0
20
40
60
80
100
120
140
160
180
1 2 3 4
Sarja1
Sarja2
LVP
JAN FEB
2014 - 2015 CVS
JAN - FEB
2014 2015
3rd level US
JAN - FEB
2014 2015 Gen. counseling
(midwife)
JAN - FEB
2014 2015
FMC Helsinki data Jan-Feb 2014 vs 2015
LVP-Amniocentesis
CVS-Chorionic villus sampling
Jan-Feb 50/70 (71.4%) suitable for NIPT have
chosen NIPT
Turnover time 9 days
All had ≥ 4% fetal fraction
1.3.-31.3.3 29/36 = 80.5%
TOTAL UPTAKE 79/106 = 74.5%, so far all NEGATIVE
-How to improve DR?
-Spreading the repertoire?
single gene disorders?
-Financial resources
-The unified screening policy on
the national level

Vedran stefanovic nipt_finland

  • 1.
    NIPT in Finland PrivateClinics Helsinki University Hospital (preparations for implementation) Implementation and immediate evaluation Other University Hospitals ? 2013 10/2014 – 12/2014 1.1.2015 autumn 2015 Vedran Stefanovic Fetomaternal Medical Center Helsinki University Hospital Finland Vedran.stefanovic@hus.fi
  • 2.
    1.1.2015  1.FTS risk≥ 1:250 2.Nuchal translucency 3-3.9 mm 3.Mid-trimester screen positive 4. > 40 yrs + FTS unattended 5. Previous child/fetus with aneuploidy (21.13 and 18 trisomy, sex-chromosomes aneuploidy) CVS (ad H14+6) OR Amnio (H15+0 ) 21,18 ja 13-trisomy and sex-chromosomes PCR Abnormal result Counselling 1.Nuchal translucency ≥ 4 mm 2.Structural anomaly CVS (ad H14+6) OR AMNIO(H15+0)- Karyotype ( + microarray) Counselling: (patients´s choice: invasive or NIPT) Counselling NIPT Normal result Abnormal result or inconclusive No follow-up Counselling Amnio 21,18 ja 13-trisomy and sex- chromosomes PCR Counselling * * NIPT= Non-Invasive Prenatal Testing Vedran Stefanovic® 12/2014
  • 3.
    57 56 168 94 51 23 163 127 0 20 40 60 80 100 120 140 160 180 1 23 4 Sarja1 Sarja2 LVP JAN FEB 2014 - 2015 CVS JAN - FEB 2014 2015 3rd level US JAN - FEB 2014 2015 Gen. counseling (midwife) JAN - FEB 2014 2015 FMC Helsinki data Jan-Feb 2014 vs 2015 LVP-Amniocentesis CVS-Chorionic villus sampling Jan-Feb 50/70 (71.4%) suitable for NIPT have chosen NIPT Turnover time 9 days All had ≥ 4% fetal fraction 1.3.-31.3.3 29/36 = 80.5% TOTAL UPTAKE 79/106 = 74.5%, so far all NEGATIVE
  • 5.
    -How to improveDR? -Spreading the repertoire? single gene disorders? -Financial resources -The unified screening policy on the national level